Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
16.4M
-
Number of holders
-
56
-
Total 13F shares, excl. options
-
12.2M
-
Shares change
-
+9.1M
-
Total reported value, excl. options
-
$314M
-
Value change
-
+$233M
-
Number of buys
-
45
-
Number of sells
-
-9
-
Price
-
$25.60
Significant Holders of ASSEMBLY BIOSCIENCES, INC. - Common Stock (ASMB) as of Q3 2025
65 filings reported holding ASMB - ASSEMBLY BIOSCIENCES, INC. - Common Stock as of Q3 2025.
ASSEMBLY BIOSCIENCES, INC. - Common Stock (ASMB) has 56 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.2M shares
of 16.4M outstanding shares and own 74.84% of the company stock.
Largest 10 shareholders include GILEAD SCIENCES, INC. (4.51M shares), FARALLON CAPITAL MANAGEMENT LLC (1.23M shares), RA CAPITAL MANAGEMENT, L.P. (1.02M shares), Commodore Capital LP (1M shares), JANUS HENDERSON GROUP PLC (753K shares), VANGUARD GROUP INC (502K shares), Frazier Life Sciences Management, L.P. (456K shares), Blackstone Inc. (448K shares), Point72 Asset Management, L.P. (296K shares), and Parkman Healthcare Partners LLC (251K shares).
This table shows the top 56 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.